California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Haridwar (Uttarakhand) [India], June 23 (ANI): Patanjali on Tuesday launched 'Coronil and Swasari', what it claims is the Ayurvedic cure for treating COVID-19, which they said has been shown 100 per cent favourable results during clinical trials on affected patients, at Patanjali Yogpeeth
Geneva [Switzerland], June 23 (ANI): The World Health Organisation (WHO) on Sunday (local time) emphasised on a rapid increase in production of dexamethasone, a cheap steroid which after clinical trials has shown life-saving potential for critically ill COVID-19 patients.
Washington D.C. [USA], June 17 (ANI): Infectious disease experts are advocating for earlier actions to reduce hospitalizations and deaths from COVID-19.
Boston [USA], June 16 (ANI): In its first randomised clinical trial, investigators report a drug that targets a protein needed by cancer cells to maintain their dogged growth and division has shown considerable promise in combination with chemotherapy in patients with a common form of ovaria
London [UK], June 14 (ANI): Results from the first-ever randomised clinical trial in advanced anal cancer patients has led to a practice-changing milestone with a new approach to treatment which is safer and more effective than previously recommended treatments for this group of patients.
Haridwar (Uttarakhand) [India], June 13 (ANI): Acharya Balkrishna, Chief Executive Officer (CEO) of Patanjali, on Saturday, claimed that an Ayurvedic medicine developed by the company has been able to cure COVID-19 patients within 5-14 days.
Ahmedabad (Gujarat) [India], June 13 (ANI): Healthcare major Zydus Cadila has signed a non-exclusive licensing agreement with Gilead Sciences Inc for the manufacturing and distribution of Remdesivir, the investigational drug which has been issued an emergency use authorisation by the US Food
New Delhi [India], June 8 (ANI): The Union Health Ministry has drafted the new rules for import of unapproved new drug for only 'compassionate Use' for treatment of patients by hospitals or medical institutions under New Drugs and Clinical Trials Rules, 2019.
New Delhi [India], June 6 (ANI): Clinical trials of the plant-derived drug, ACQH, to treat COVID-19 patients that began on Friday in India has been hailed by the Council of Scientific and Industrial Research (CSIR) as "historic in modern medicine".
Mumbai (Maharashtra) [India], June 5 (ANI): Sun Pharmaceutical Industries has started phase two clinical trial on AQCH, a phytopharmaceutical (plant-derived) drug for the treatment of COVID-19.
New Delhi [India], June 4 (ANI/NewsVoir): Dalmia Healthcare, the healthcare division of Dalmia Group led by renowned industrialist Sanjay Dalmia, starts clinical trial to evaluate the efficacy and safety of polyherbal combination "Astha-15" for treatment of COVID-19.